CHINA FINANCE ONLINE CO-ADR (JRJC) Fundamental Analysis & Valuation

NASDAQ:JRJC

Current stock price

3.99
-2.45 (-38.04%)
At close:
4.15
+0.16 (+4.01%)
After Hours:

This JRJC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. JRJC Profitability Analysis

1.1 Basic Checks

  • In the past year JRJC has reported negative net income.
JRJC Yearly Net Income VS EBIT VS OCF VS FCFJRJC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 0 0 0 0

1.2 Ratios

Industry RankSector Rank
ROA -14.95%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JRJC Yearly ROA, ROE, ROICJRJC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 -20 -40 -60 -80 -100

1.3 Margins

Industry RankSector Rank
OM -28%
PM (TTM) -26.5%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JRJC Yearly Profit, Operating, Gross MarginsJRJC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. JRJC Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for JRJC remains at a similar level compared to 1 year ago.
  • JRJC has a worse debt/assets ratio than last year.
JRJC Yearly Shares OutstandingJRJC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 50K 100K 150K 200K
JRJC Yearly Total Debt VS Total AssetsJRJC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 6.09 indicates that JRJC is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.31 indicates that JRJC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 6.09
ROIC/WACCN/A
WACCN/A
JRJC Yearly LT Debt VS Equity VS FCFJRJC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that JRJC may have some problems paying its short term obligations.
  • A Quick Ratio of 0.91 indicates that JRJC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
JRJC Yearly Current Assets VS Current LiabilitesJRJC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. JRJC Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.52% over the past year.
  • The earnings per share for JRJC have been decreasing by -67.27% on average. This is quite bad
  • JRJC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.68%.
  • JRJC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -17.92% yearly.
EPS 1Y (TTM)6.52%
EPS 3Y-67.27%
EPS 5YN/A
EPS Q2Q%-238.92%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y-2.08%
Revenue growth 5Y-17.92%
Sales Q2Q%51.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JRJC Yearly Revenue VS EstimatesJRJC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

0

4. JRJC Valuation Analysis

4.1 Price/Earnings Ratio

  • JRJC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JRJC Price Earnings VS Forward Price EarningsJRJC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.54
JRJC Per share dataJRJC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. JRJC Dividend Analysis

5.1 Amount

  • No dividends for JRJC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

JRJC Fundamentals: All Metrics, Ratios and Statistics

CHINA FINANCE ONLINE CO-ADR

NASDAQ:JRJC (1/20/2022, 8:18:38 PM)

After market: 4.15 +0.16 (+4.01%)

3.99

-2.45 (-38.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)03-01
Inst Owners0.51%
Inst Owner Change-90.42%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.74M
Revenue(TTM)40.00M
Net Income(TTM)-10.60M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB N/A
EV/EBITDA -0.54
EPS(TTM)-4.6
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS16.38
BVpS4.31
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -28%
PM (TTM) -26.5%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z 6.09
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.52%
EPS 3Y-67.27%
EPS 5YN/A
EPS Q2Q%-238.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.68%
Revenue growth 3Y-2.08%
Revenue growth 5Y-17.92%
Sales Q2Q%51.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CHINA FINANCE ONLINE CO-ADR / JRJC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHINA FINANCE ONLINE CO-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to JRJC.


Can you provide the valuation status for CHINA FINANCE ONLINE CO-ADR?

ChartMill assigns a valuation rating of 2 / 10 to CHINA FINANCE ONLINE CO-ADR (JRJC). This can be considered as Overvalued.


How profitable is CHINA FINANCE ONLINE CO-ADR (JRJC) stock?

CHINA FINANCE ONLINE CO-ADR (JRJC) has a profitability rating of 1 / 10.


Can you provide the financial health for JRJC stock?

The financial health rating of CHINA FINANCE ONLINE CO-ADR (JRJC) is 4 / 10.